XML 38 R17.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
STOCK WARRANTS
12 Months Ended
Sep. 30, 2019
Accounting Policies [Abstract]  
STOCK WARRANTS

The following is a summary of stock warrant activity during the years ended September 30, 2019 and September 30, 2018.

 

   Number of Warrant Shares  Weighted Average Exercise Price
Balance, September 30, 2017   861,210   $8.50
Warrants granted   119,160    8.00
Warrants expired   —      —  
Warrants canceled   —      —  
Warrants exercised   (81,440)   3.60
Balance, September 30, 2018   898,930   $8.90
Warrants granted   641,333   $32.20
Warrants expired   —      —  
Warrants canceled   —      —  
Warrants exercised   (226,200)   0.80
Balance, September 30, 2019   1,314,063   $21.70

 

As of September 30, 2019, the outstanding warrants have a weighted average remaining term of was 2.86 years and an intrinsic value of $880,574.

 

As of September 30, 2019, there are warrants exercisable to purchase 1,274,063 shares of common stock in the Company and 40,000 unvested warrants outstanding that cannot be exercised until vesting conditions are met. 996,198 of the warrants require a cash investment to exercise as follows, 5,000  required a cash investment of $8.00 per share, 449,865 require a cash investment of $15.00 per share, 125,000 require a cash investment of $20.00 per share, 103,000 require a cash investment of $25.00 per share, 200,000 require an investment of $35.00 per share, 10,000 require an investment of $40.00 per share, 60,000 require an investment of $50.00 per share, 38,333 require a cash investment of $75.00 per share and 5,000 require a cash investment of $100.00 per share. 317,865 of the outstanding warrants contain provisions allowing a cashless exercise at their respective exercise prices.

 

Warrant activity for the year ended September 30, 2019

 

On October 15, 2018, the Company entered into an agreement with a consultant for services. Under this agreement the Company agreed to issue 3,000 warrants to purchase shares of the Company’s common stock at an exercise price of $25.00 for a period of five years which vest evenly over a six-month period from the agreement date. During the year ended September 30, 2019, the Company recorded stock compensation of $68,643 as a result of the stock issued under the agreement. The warrants were valued using the black-Scholes valuation model.

 

On December 31, 2018, in connection with a Securities purchase agreement (see Note 8 for additional details) the Company issued Common Stock Purchase Warrants to acquire up to 308,333 shares of common stock for a term of three years on a cash-only basis at an exercise price of $20.00 per share with respect to 125,000 Warrant Shares, $25.00 with respect to 100,000 Warrant Shares, $50.00 with respect to 50,000 Warrant Shares and $75.00 with respect to 33,333 Warrant Shares.

 

On April 18, 2019, in connection with a Securities purchase agreement (see Note 8 for additional details) the Company issued Common Stock Purchase Warrants to acquire up to 230,000 shares of common stock for a term of three years on a cash-only basis at an exercise price of $35.00 per share with respect to 200,000 Warrant Shares, $40.00 with respect to 10,000 Warrant Shares, $50.00 with respect to 10,000 Warrant Shares, $75.00 with respect to 5,000 Warrant Shares and $100.00 with respect to 5,000 Warrant Shares.

 

On August 28, 2018, in connection with the Consulting agreement executed with Zero Positive, LLC the Company issued warrants to purchase 90,000 shares of common stock at an exercise price of $8.00 per share to Zero Positive. The warrants were valued at $2,607,096 using the Black Scholes option pricing model. The warrants vest as follows: 30,000 warrants vested immediately, the balance vest evenly on the last day of each month over the forty-two months beginning August 31, 2018. As of September 30, 2019, 50,000 warrants had vested, and the Company recorded an expense of $496,590 during the year ended September 30, 2019. (See Note 9 for additional details.)

 

On January 22, 2019, in accordance with a merger agreement, CleanSpark issued; a five-year warrant to purchase 50,000 shares of CleanSpark common stock at an exercise price of $16.00 per share, and a five-year warrant to purchase 50,000 shares of CleanSpark common stock at an exercise price of $20.00 per share. (see note 3 for additional details.) The warrants were valued at $1,102,417 and $1,102,107, respectively.

 

The Black-Scholes model utilized the following inputs to value the warrants granted during the year ended September 30, 2019:

 

Fair value assumptions – Warrants:  September 30, 2019
Risk free interest rate   2.36% - 3.01%
Expected term (years)   3-5
Expected volatility   254% - 268%
Expected dividends   0%

 

On January 7, 2019, a total of 144,417 shares of the Company’s common stock were issued in connection with the cashless exercise of 150,000 common stock warrants with an exercise prices of $0.83.

 

On February 26, 2019, a total of 24,623 shares of the Company’s common stock were issued in connection with the cashless exercise of 25,000 common stock warrants at an exercise price of $0.83.

 

On March 26, 2019, a total of 48,857 shares of the Company’s common stock were issued in connection with the cashless exercise of 50,000 common stock warrants at an exercise price of $0.83.

 

As of September 30, 2019, the Company expects to recognize $1,158,709 of stock-based compensation for the non-vested outstanding warrants over a weighted-average period of 2.26 years.

 

Warrant activity for the year ended September 30, 2018

 

During the year ended September 30, 2018, certain investors exercised warrants to purchase 25,840 shares of the Company’s common stock at purchase prices ranging from $0.83 to $15.00. The Company received total proceeds of $44,938 from the warrant exercises.

 

During the year ended September 30, 2018, a total of 45,989 shares of the Company’s common stock were issued in connection with the cashless exercise of 55,600 common stock warrants with an exercise prices of $3.60.

 

On January 1, 2018, the Company issued warrants to purchase 10,000 shares of common stock at an exercise price of $8.00 per share to an advisor for business advisory services. The warrants were valued at $234,095 using the Black Scholes option pricing model. The warrants vest evenly over the six-month service period ended September 30, 2018.

 

On June 15, 2018, the Company issued 11,660 5-year warrants exercisable at $8.00 to a lender in connection with a promissory note agreement. (See Note 8 for additional details.)

 

On August 1, 2018, the Company issued 2,500 5-year warrants exercisable at $8.00 to a lender in connection with a promissory note agreement. (See Note 8 for additional details.)

 

On August 28, 2018, in connection with the Consulting agreement executed with Zero Positive, LLC. the Company issued warrants to purchase 90,000 shares of common stock at an exercise price of $8.00 per share to Zero Positive. The warrants were valued at $2,607,096 using the Black Scholes option pricing model. The warrants vest as follows: 30,000 warrants vested immediately, the balance vest evenly on the last day of each month over the forty-two months beginning August 31, 2018. As of September 30, 2018, 32,857 warrants had vested, and the Company recorded an expense of $951,797 during the year ended September 30, 2018. (See Note 9 for additional details.)

 

On September 20, 2018, the Company issued 2,500 5-year warrants exercisable at $8.00 to a lender in connection with a promissory note agreement. (See Note 8 for additional details.)

 

On September 21, 2018, the Company issued 2,500 5-year warrants exercisable at $8.00 to a lender in connection with a promissory note agreement. (See Note 8 for additional details.)

 

The Black-Scholes model utilized the following inputs to value the warrants granted during the year ended September 30, 2018:

 

Fair value assumptions – Warrants:  September 30, 2018
Risk free interest rate   2.01% - 3.05%
Expected term (years)   5-10
Expected volatility   158% - 265%
Expected dividends   0%